Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antiviral compound, and preparation method and application of compound

A compound and antiviral technology, applied in biochemical equipment and methods, antiviral agents, microbial-based methods, etc., can solve the problems of strong toxicity and side effects, expensive drugs, etc., achieve strong antiviral activity, simple separation and purification, Good dose-dependent effect

Active Publication Date: 2018-02-09
WUHAN UNIV
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the U.S. Food and Drug Administration has approved more than 20 drugs for AIDS treatment, but these drugs are expensive and have strong toxic and side effects, which will induce the emergence of drug-resistant strains of the virus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral compound, and preparation method and application of compound
  • Antiviral compound, and preparation method and application of compound
  • Antiviral compound, and preparation method and application of compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] The features and advantages of the present invention can be further understood from the following detailed description in conjunction with the accompanying drawings. The examples provided are merely illustrative of the methods of the present invention, and are not intended to limit the remainder of the present disclosure in any way. [Example 1] Construction of enterocin biosynthesis gene cluster deletion mutant Δenc

[0041] Using the genomic DNA of wild-type 172205 as a template, primers enc-L1 (5'-CCTAGGCAGTTCCATCACCCCGTTCG-3', SEQ NO.1) and enc-L2 (5'-AAGCTTGTCGTCGCAGCAGCAGTTCG-3', SEQ NO.2) were designed for amplification. The upstream fragment enc-L of the enterocin synthetic gene cluster was increased, and the primers enc-R1 (5'-CATATGAGAGGGCGGACGGGAACTGC-3', SEQ NO.3) and enc-R2 (5'-CCTAGGGCGCCATCCCAACGGGCTAC-3', SEQ NO.4) were designed for Amplification of the enc-R fragment downstream of the enterocin synthetic gene cluster. 20 μL PCR reaction system using Ta...

Embodiment 2

[0045] [Example 2] Mass fermentation of mutant strain 172205Δenc and method for pretreatment of fermented product samples

[0046] The mutant strain 172205Δenc obtained in Example 1 was inoculated into ISP2 liquid medium, cultured at 28°C and 200 r / min for 3 days, and transferred to 12 shake flasks with 100 mL fermentation medium at 5% inoculum at 28°C. , 200r / min and continue to cultivate for 7d to obtain fermentation broth. The fermentation broth was directly extracted three times with an equal volume of ethyl acetate, during which time ultrasonication and shaking were performed for several times, the ethyl acetate layers were combined, and concentrated to dryness under reduced pressure at 35° C. to obtain a crude extract. The ISP2 liquid medium consists of the following components: 4 g / L of glucose, 4 g / L of yeast extract, 10 g / L of malt extract, and the pH value is 7.2. The fermentation medium is composed of the following components: glucose 20g, soluble starch 10g, yeast...

Embodiment 3

[0047] [Example 3] Isolation and structure confirmation of compounds

[0048] (1) Compound separation

[0049] About 1 g of the crude extract obtained in Example 2 was dissolved in an appropriate amount of methanol, and then stirred into reverse silica gel. The eluate of the target component was concentrated and then separated and purified using C18 semi-preparative liquid phase using acetonitrile and water with a mobile phase ratio of 30:70 (volume ratio) to obtain the target compound (4 mg).

[0050] (2) Confirmation of plane structure

[0051] by UV( image 3 ), IR( Figure 4 ), MS( Figure 5 ) and NMR ( Figure 6-10 ) various spectroscopic methods, the structure of the above compound was determined, and its physicochemical properties and spectral data are as follows:

[0052] Light brown powder; Optical rotation: Molecular formula: C 17 H 13 NO 9 ; Molecular weight: 375; HRESI-MS (m / z): 376.0665 [M+H] + (calcd.for C 17 H 14 NO 9 , 376.0663); UVλmax(logε) MeO...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound with antiviral activity and a preparation method and application of the compound. The compound has a structure shown in a formula (I) and can be prepared and obtained by fermentation and separation of a mutant strain with the deletion of the enterocin gene cluster of Streptomycete qinglanensis 1772205. A high-resolution mass spectrum and a nuclear magnetic resonance spectrum technology are adopted to confirm the structure of the compound. The compound with a structure shown as in the formula (I) has relatively strong antiviral activity and can be used for preparing medicines for treating viruses.

Description

technical field [0001] The invention belongs to the field of microbial medicines, in particular to a new compound with antiviral activity and its preparation method and application. Background technique [0002] Human immunodeficiency virus (human immunodeficiency virus, HIV), that is, AIDS virus, can cause defects in the human immune system. It was first discovered in the United States in 1981. According to the statistics of the World Health Organization, as of the end of 2014, there were about 36.9 million people living with HIV worldwide, about 2 million people were newly infected with HIV and 1.2 million people died of HIV-related causes in the same year. Due to the rapid mutation of the HIV virus, there is no effective cure so far, but some drugs have been developed that can inhibit the activity of the virus, slow down the course of the disease, and reduce the mortality and morbidity after infection. Due to the lag and insufficient popularization of AIDS education in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D311/80C12P17/06A61K31/352A61P31/18C12R1/465
CPCC07D311/80C12P17/06
Inventor 洪葵徐东波田二丽庄柯刘航邓子新
Owner WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com